Active Tech, a company specializing in invasive brain-computer interface technology, has successfully concluded an angel round of financing, raising RMB 330 million. The funding round was spearheaded by CAS Star and saw contributions from a consortium of institutions. The capital infusion will be strategically allocated towards site expansion, upgrading of equipment, progression of clinical trials, and augmentation of the team, with the overarching goal of expediting the clinical translation and industrialization of their products. This latest financing achievement marks a new benchmark for angel round investments within China's brain-computer interface industry.